{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:54:26Z","timestamp":1740178466030,"version":"3.37.3"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013684","name":"Christie Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010049","name":"Kingston University","doi-asserted-by":"publisher","award":["AC18048","NCT04081428"],"award-info":[{"award-number":["AC18048","NCT04081428"]}],"id":[{"id":"10.13039\/100010049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["tipsro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Technical Innovations & Patient Support in Radiation Oncology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.tipsro.2024.100267","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T18:27:05Z","timestamp":1722882425000},"page":"100267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical implementation of real time motion management for prostate SBRT: A radiation therapist\u2019s perspective"],"prefix":"10.1016","volume":"31","author":[{"given":"Joanne","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9862-4158","authenticated-orcid":false,"given":"Duncan B.","family":"McLaren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Burns Pollock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joella","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1463-7793","authenticated-orcid":false,"given":"Angus","family":"Killean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Trainer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Adamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"McKernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Nailon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tipsro.2024.100267_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-9-1","article-title":"Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study","volume":"9","author":"Katz","year":"2014","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.tipsro.2024.100267_b0010","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ijrobp.2010.10.075","article-title":"Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: \u03b1\/\u03b2 = 1.4 (0.9-2.2) Gy","volume":"82","author":"Miralbell","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10196","key":"10.1016\/j.tipsro.2024.100267_b0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.tipsro.2024.100267_b0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2013.09.026","article-title":"Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local, biochemical, clinical failure, and survival","volume":"110","author":"Heemsbergen","year":"2014","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.tipsro.2024.100267_b0025","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.tipsro.2024.100267_b0030","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tipsro.2024.100267_b0035","doi-asserted-by":"crossref","unstructured":"Van As N., Tree A., Patel J., Ostler P., Van Der Voet H., Loblaw D.A., Chu W., Ford D., Tolan S., Jain S., Armstrong J.G., Camilleri P., Kancherla K., Frew J., Chan A., Naismith O., Manning G., Brown S., Griffin C., Hall E. 5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated External Beam Radiotherapy for Localized Prostate Cancer.Int J Radiat Oncol Biol Phys. Volume 117, Issue 4, 15 November 2023, Pages e2-e3 Doi: 10.1016\/j.ijrobp.2023.08.027.","DOI":"10.1016\/j.ijrobp.2023.08.027"},{"key":"10.1016\/j.tipsro.2024.100267_b0040","first-page":"40","article-title":"Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer","volume":"29","author":"Houben","year":"2021","journal-title":"Clin TranslRadiatOncol"},{"key":"10.1016\/j.tipsro.2024.100267_b0045","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fonc.2020.00469","article-title":"Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial","volume":"10","author":"Heemsbergen","year":"2020","journal-title":"Front Oncol"},{"issue":"16","key":"10.1016\/j.tipsro.2024.100267_b0050","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S1470-2045(15)00280-6","article-title":"Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"16","author":"Wilkins","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.tipsro.2024.100267_b0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijrobp.2011.11.047","article-title":"Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer","volume":"84","author":"Zelefsky","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.tipsro.2024.100267_b0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clon.2013.08.008","article-title":"Stereotactic body radiotherapy in prostate cancer: is rapidarc a better solution than cyberknife?","volume":"26","author":"Macdougall","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"7","key":"10.1016\/j.tipsro.2024.100267_b0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clon.2012.05.002","article-title":"Expert Panel MotII. Intensity-modulated radiotherapy in the treatment of prostate cancer","volume":"24","author":"Bauman","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1016\/j.tipsro.2024.100267_b0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.meddos.2005.03.005","article-title":"A review of prostate motion with considerations for the treatment of prostate cancer","volume":"30","author":"Byrne","year":"2005","journal-title":"Med Dosim"},{"issue":"3","key":"10.1016\/j.tipsro.2024.100267_b0075","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijrobp.2014.10.049","article-title":"Continuous monitoring and intrafraction target position correction during treatment improves target coverage for patients undergoing SBRT prostate therapy","volume":"91","author":"Lovelock","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.tipsro.2024.100267_b0080","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1088\/0031-9155\/58\/7\/2413","article-title":"The random walk model of intrafraction movement","volume":"58","author":"Ballhausen","year":"2013","journal-title":"Phys Med Biol"},{"issue":"6","key":"10.1016\/j.tipsro.2024.100267_b0085","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0360-3016(91)90244-X","article-title":"Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder","volume":"20","author":"Ten Haken","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.tipsro.2024.100267_b0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/mp.16094","article-title":"The dosimetric error due to uncorrected tumor rotation during real-time adaptive prostate stereotactic body radiation therapy","volume":"50","author":"Sengupta","year":"2023","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.tipsro.2024.100267_b0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijrobp.2018.01.040","article-title":"Determination of Intrafraction Prostate Motion During External Beam Radiation Therapy With a Transperineal 4-Dimensional Ultrasound Real-Time Tracking System","volume":"101","author":"Sihono","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tipsro.2024.100267_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2022.109441","article-title":"SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: An analysis of the dosimetric impact of intra-fractional organ changes","volume":"179","author":"Brennan","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.tipsro.2024.100267_b0105","doi-asserted-by":"crossref","DOI":"10.1007\/s13246-023-01242-7","article-title":"Intrafraction motion during CyberKnife\u00ae prostate SBRT: impact of imaging frequency and patient factors","author":"Rose","year":"2023","journal-title":"Phys Eng Sci Med"},{"issue":"2","key":"10.1016\/j.tipsro.2024.100267_b0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.radonc.2010.01.010","article-title":"Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers","volume":"95","author":"Kron","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.tipsro.2024.100267_b0115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13014-014-0262-y","article-title":"Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)","volume":"9","author":"Gladwish","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.tipsro.2024.100267_b0120","doi-asserted-by":"crossref","unstructured":"de Muinck Keizer DM, Kerkmeijer LGW, Willigenburg T, van Lier ALHM, Hartogh MDD, van der Voort van Zyp JRN, et al. Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac. Radiother Oncol 2020;151:88-94. DOI: 10.1016\/j.radonc.2020.06.044.","DOI":"10.1016\/j.radonc.2020.06.044"},{"key":"10.1016\/j.tipsro.2024.100267_b0125","unstructured":"Falco MLaT. Intrafractional prostate motion management with the clarity autoscan system. Med Phys Int J 2013;vol.1, No.1."},{"key":"10.1016\/j.tipsro.2024.100267_b0130","doi-asserted-by":"crossref","unstructured":"Langen KM, Willoughby TR, Meeks SL, Santhanam A, Cunningham A, Levine L, et al. Observations on real-time prostate gland motion using electromagnetic tracking. Int J Radiat Oncol Biol Phys. 2008;71(4):1084-90 DOI: 10.1016\/j.ijrobp.2007.11.054.","DOI":"10.1016\/j.ijrobp.2007.11.054"},{"issue":"4","key":"10.1016\/j.tipsro.2024.100267_b0135","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijrobp.2006.10.026","article-title":"Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy","volume":"67","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.tipsro.2024.100267_b0140","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.ijrobp.2012.01.046","article-title":"The dosimetric effect of intrafraction prostate motion on step-and-shoot intensity-modulated radiation therapy plans: magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans","volume":"84","author":"Langen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tipsro.2024.100267_b0145","unstructured":"https:\/\/www.cancerresearchuk.org\/about-cancer\/find-a-clinical-trial\/study-using-breath-predict-what-happens-tissue-during-radiotherapy-prostate-cancer-PRINToUT."},{"key":"10.1016\/j.tipsro.2024.100267_b0150","doi-asserted-by":"crossref","unstructured":"van Herk M, Bruce A, Kroes AP, Shouman T, Touw A, Lebesque JV. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys. 1995;33(5):1311-20. DOI: 10.1016\/0360-3016(95)00116-6.","DOI":"10.1016\/0360-3016(95)00116-6"},{"issue":"3","key":"10.1016\/j.tipsro.2024.100267_b0155","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ijrobp.2005.08.016","article-title":"Prostate position variability and dose-volume histograms in radiotherapy for prostate cancer with full and empty bladder","volume":"64","author":"Pinkawa","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tipsro.2024.100267_b0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tipsro.2017.10.001","article-title":"The impact of bladder preparation protocols on post treatment toxicity in radiotherapy for localised prostate cancer patients","volume":"3\u20134","author":"Tsang","year":"2017","journal-title":"Tech Innov Patient Support Radiat Oncol"}],"container-title":["Technical Innovations & Patient Support in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632424000349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632424000349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T15:32:38Z","timestamp":1728055958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405632424000349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":32,"alternative-id":["S2405632424000349"],"URL":"https:\/\/doi.org\/10.1016\/j.tipsro.2024.100267","relation":{},"ISSN":["2405-6324"],"issn-type":[{"type":"print","value":"2405-6324"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical implementation of real time motion management for prostate SBRT: A radiation therapist\u2019s perspective","name":"articletitle","label":"Article Title"},{"value":"Technical Innovations & Patient Support in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tipsro.2024.100267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100267"}}